The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Legrand, Matthieu, Oufella, Hafid Ait, De Backer, Daniel, Duranteau, Jacques, Leone, Marc, Levy, Bruno, Rossignol, Patrick, Vicaut, Eric, Dépret, François
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://ncbi.nlm.nih.gov/pubmed/32611377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04549-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars